SCHEMBL20069033

SCHEMBL20069033

CN1CCC(N)(N)CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2951642 0.78
Hydrochloric Acid SCHEMBL17749000 0.75 OPRM1 (0.34)
SCHEMBL13321357 0.75
SCHEMBL10514616 0.75
Hydrochloric Acid SCHEMBL19747840 0.75 OPRM1 (0.34)
SCHEMBL26622624 0.75
SCHEMBL1753867 0.72 TSHR (0.43)
SCHEMBL20069036 0.71 CHRM2 (0.34)
SCHEMBL16451672 0.71 DRD4 (0.30)
SCHEMBL3506624 0.71 NCF1 (0.37)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113583021-B Synthesis method of spiropiperidine rifamycin 漯河启福医药科技有限公司 2023-05-23 CN disclosed
CN-113583021-A Synthesis method of spiropiperidine rifamycin 四川樵枫科技发展有限公司 2021-11-02 CN disclosed
US-20200187500-A1 PYRIDINE COMPOUNDS BASF SE (DE) 2020-06-18 US disclosed
WO-2018071454-A1 SUBSTITUTED PYRAZOLO[1,5-A]PYRIDINE COMPOUNDS AS RET KINASE INHIBITORS ANDREWS STEVEN W (US) 2018-04-19 WO disclosed